日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Methylobacterium populi Urease accessory protein UreD 2 (ureD2) CSB-YP463831MTC
CSB-EP463831MTC
CSB-BP463831MTC
CSB-MP463831MTC
CSB-EP463831MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium populi 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP463832MTC
CSB-EP463832MTC
CSB-BP463832MTC
CSB-MP463832MTC
CSB-EP463832MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium populi Formate--tetrahydrofolate ligase (fhs), partial CSB-YP463833MTC
CSB-EP463833MTC
CSB-BP463833MTC
CSB-MP463833MTC
CSB-EP463833MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium populi DNA-directed RNA polymerase subunit omega (rpoZ) CSB-YP463834MTC
CSB-EP463834MTC
CSB-BP463834MTC
CSB-MP463834MTC
CSB-EP463834MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium populi UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP463835MTC
CSB-EP463835MTC
CSB-BP463835MTC
CSB-MP463835MTC
CSB-EP463835MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium populi 50S ribosomal protein L27 (rpmA) CSB-YP463836MTC
CSB-EP463836MTC
CSB-BP463836MTC
CSB-MP463836MTC
CSB-EP463836MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium populi 50S ribosomal protein L4 (rplD) CSB-YP463837MTC
CSB-EP463837MTC
CSB-BP463837MTC
CSB-MP463837MTC
CSB-EP463837MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium populi Aspartyl/glutamyl-tRNA (Asn/Gln) amidotransferase subunit C CSB-YP463838MTC
CSB-EP463838MTC
CSB-BP463838MTC
CSB-MP463838MTC
CSB-EP463838MTC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae Transcriptional repressor NrdR (nrdR) CSB-YP463839OEN
CSB-EP463839OEN
CSB-BP463839OEN
CSB-MP463839OEN
CSB-EP463839OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae 50S ribosomal protein L24 (rplX) CSB-YP463840OEN
CSB-EP463840OEN
CSB-BP463840OEN
CSB-MP463840OEN
CSB-EP463840OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae 50S ribosomal protein L2 (rplB) CSB-YP463841OEN
CSB-EP463841OEN
CSB-BP463841OEN
CSB-MP463841OEN
CSB-EP463841OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase (kduI) CSB-YP463842OEN
CSB-EP463842OEN
CSB-BP463842OEN
CSB-MP463842OEN
CSB-EP463842OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae Protein-L-isoaspartate O-methyltransferase (pcm) CSB-YP463843OEN
CSB-EP463843OEN
CSB-BP463843OEN
CSB-MP463843OEN
CSB-EP463843OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae 3-dehydroquinate synthase (aroB) CSB-YP463844OEN
CSB-EP463844OEN
CSB-BP463844OEN
CSB-MP463844OEN
CSB-EP463844OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae L-arabinose isomerase (araA), partial CSB-YP463845OEN
CSB-EP463845OEN
CSB-BP463845OEN
CSB-MP463845OEN
CSB-EP463845OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae Aspartate--tRNA ligase (aspS), partial CSB-YP463846OEN
CSB-EP463846OEN
CSB-BP463846OEN
CSB-MP463846OEN
CSB-EP463846OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae GTP cyclohydrolase folE2 (folE2) CSB-YP463847OEN
CSB-EP463847OEN
CSB-BP463847OEN
CSB-MP463847OEN
CSB-EP463847OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae Putative ribosome biogenesis GTPase RsgA (rsgA) CSB-YP463848OEN
CSB-EP463848OEN
CSB-BP463848OEN
CSB-MP463848OEN
CSB-EP463848OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae Glycogen synthase (glgA) CSB-YP463849OEN
CSB-EP463849OEN
CSB-BP463849OEN
CSB-MP463849OEN
CSB-EP463849OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Opitutus terrae Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta (accD) CSB-YP463850OEN
CSB-EP463850OEN
CSB-BP463850OEN
CSB-MP463850OEN
CSB-EP463850OEN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×